Montreal – Lallemand has acquired of Swiss biotechnology business Evolva AG through its subsidiary Danstar Ferment AG.
Evolva is focused on the research, development and commercialization of natural ingredients derived from yeast for applications across the flavours and fragrances, health ingredients, cosmetics and health protection sectors. Evolva is headquartered in Reinach, Basel, with 48 employees. Its parent company is Evolva Holding AG.
Lars Asferg, president of Lallemand Bio-Ingredients, said: “Evolva’s proprietary precision fermentation technology and R&D capabilities present an ideal platform from which to expand our product offering mainly within health ingredients like Veri-te resveratrol and flavour and fragrance aroma components like Valencene and natural Nootkatone.”
